Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Meloxicam sodium
Drug ID BADD_D01375
Description Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve various types of pain, including pain caused by musculoskeletal conditions, osteoarthritis, and rheumatoid arthritis.[A190189] With a longer half-life than most other NSAIDS, it is a favorable option for those who require once-daily dosing. Meloxicam is available in oral, transdermal, and intravenous formulations. It is a preferential COX-2 inhibitor, purportedly reducing the risk of adverse gastrointestinal tract effects, however, this is a topic of controversy.[A190198,A190201]
Indications and Usage For symptomatic treatment of arthritis and osteoarthritis.
Marketing Status Prescription; Discontinued
ATC Code M01AC06
DrugBank ID DB00814
KEGG ID D00969
MeSH ID D000077239
PubChem ID 4051
TTD Drug ID D0G7FJ
NDC Product Code 0597-0030; 22365-116; 0615-8124; 51869-0008; 43063-396; 50090-5861; 54458-965; 60760-419; 61442-127; 63187-083; 63629-2019; 65841-051; 65862-098; 67296-1250; 68071-1994; 68071-2184; 68071-3030; 68382-050; 68382-051; 70518-0031; 71610-544; 80425-0041; 52119-003; 16571-776; 35356-808; 50090-5339; 50436-1124; 65841-050; 68071-1919; 68071-4987; 68788-7726; 68788-7904; 70518-0171; 71205-923; 71205-924; 29300-124; 50090-0986; 50268-526; 51655-577; 53002-1535; 53002-1537; 58118-1158; 63629-2020; 68788-9418; 70518-3023; 70934-010; 70954-077; 71610-516; 71610-580; 72865-137; 76282-153; 51552-1377; 53069-0790; 53104-7574; 43353-038; 43353-979; 55289-618; 61919-434; 61919-469; 64380-715; 64380-716; 71335-1956; 0597-0029; 49452-4402; 65862-223; 16571-777; 42708-007; 43063-395; 51407-611; 53002-2537; 61442-126; 67296-0583; 68180-501; 68180-502; 69097-158; 69097-159; 69344-206; 71335-0406; 71335-1888; 76420-039; 76420-043; 80425-0083; 0395-8154; 68225-112; 29300-125; 43063-401; 49999-869; 50268-525; 50436-1125; 60760-404; 60760-448; 63629-3248; 63629-3328; 67296-1317; 68071-1993; 68180-188; 70518-1828; 71335-1618; 71518-001; 17373-1157; 0615-8040; 56125-750; 65841-004; 70859-007; 55289-272; 63187-082; 68462-140; 70518-1299; 80425-0043; 80425-0045; 51927-0032; 59349-0003; 43353-127; 50090-5340; 51407-610; 51655-731; 60687-199; 68462-141; 69344-205; 70518-0039; 70518-0200; 71610-380; 71610-542; 71610-583; 72865-138; 80425-0042; 80425-0044; 17373-1158; 38779-2746; 58624-0430; 60592-994; 62938-0026; 68981-032; 42708-093; 50090-0985; 65862-097; 67296-1817; 68788-1701; 70954-076; 76282-152; 51869-0007; 53747-006; 72969-045; 45865-360; 50090-4896; 53002-2535; 54458-964; 63629-7966; 67296-0823; 68180-189; 70518-2631
Synonyms Meloxicam | Miloxicam | Parocin | Mobic | Mobicox | Mobec | Masflex | Movicox | Reumoxicam | Uticox | Movalis
Chemical Information
Molecular Formula C14H12N3NaO4S2
CAS Registry Number 71125-38-7
SMILES CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)[O-].[Na+]
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Bursitis15.04.01.001--Not Available
Cardiac failure02.05.01.001--
Cardiac failure congestive02.05.01.002--Not Available
Carpal tunnel syndrome17.09.02.001--Not Available
Cataract06.06.01.001--
Colitis07.08.01.001--
Confusional state19.13.01.001; 17.02.03.005--
Conjunctivitis11.01.06.012; 06.04.01.002--
Constipation07.02.02.001--
Cough22.02.03.001--
Creatinine renal clearance decreased13.13.01.013--Not Available
Dehydration14.05.05.001--
Dermatitis23.03.04.002--Not Available
Dermatitis bullous23.03.01.002--
Dermatitis exfoliative23.03.07.001; 10.01.01.004--
Diarrhoea07.02.01.001--
Discomfort08.01.08.003--Not Available
Disorientation19.13.01.002; 17.02.05.015--Not Available
Dizziness24.06.02.007; 17.02.05.003; 02.01.02.004--
Drug interaction08.06.03.001--Not Available
Dry mouth07.06.01.002--
Duodenal ulcer07.04.02.002--
Duodenal ulcer perforation07.04.02.003--Not Available
Dysgeusia17.02.07.003; 07.14.03.001--
Dyspepsia07.01.02.001--
Dyspnoea22.02.01.004; 02.01.03.002--
Ear disorder04.03.01.001--Not Available
Eructation07.01.02.003--
Erythema23.03.06.001--Not Available
Erythema multiforme23.03.01.003; 10.01.03.015--
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 7 Pages